CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
September 2020—Diaceutics announced two partnerships, with Targos Molecular Pathology and HistoCyte Laboratories, on its DXRX platform, an end-to-end solution for the development and commercialization of precision medicine diagnostics.
Read More »Home >> Tag Archives: Diaceutics
Diaceutics partners with Targos, HistoCyte Labs on dx network
July 24, 2020—Diaceutics announced two partnerships, with Targos Molecular Pathology and HistoCyte Laboratories, on its DXRX platform. an end-to-end solution for the development and commercialization of precision medicine diagnostics.
Read More »Clinical laboratory test standardization key to regulatory reform
Executives at data analytics firm Diaceutics have written an article titled “Diagnostics reform and harmonization of clinical laboratory testing” in the Journal of Molecular Diagnostics.
Read More »CMS national coverage decision on next-generation sequencing
A new white paper titled “The CMS National Coverage Decision on NGS” from Diaceutics provides coverage of ongoing developments since the NGS national coverage decision was made. Read the white paper (requires free registration).
Read More »Diaceutics teams up with Lenovo and Intel
March 9, 2018—Diaceutics, based in Dundalk, Ireland, will collaborate with tech companies Lenovo and Intel to leverage their vast proprietary database of patient testing data. Diaceutics will use artificial intelligence to see whether patients can be grouped according to diagnostic test information in hopes the data can help identify ways to improve diagnosis, treatment, and outcomes for patients with similar ...
Read More »